APOLLOMICS, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2056 USD | +3.79% |
|
+5.43% | -78.66% |
| 04/06 | Apollomics Announces Vebreltinib Data At the 2024 American Society of Clinical Oncology Annual Meeting | CI |
| 08/05 | Apollomics, Inc. Appoints Robert Lin to the Board of Directors | CI |
